As part of a plan to reduce its $32.5 billion debt burden, Teva Pharmaceuticals closed offices in New York City and Washington D.C., according to The Calcalist. According to Teva’s CEO Kåre ...

Teva is working to consolidate seven U.S. offices under one roof, and that means saying bye-bye to its New York and Washington, D.C., locations. The Israeli drugmaker has already shuttered office ...

Health Canada says a pharmaceutical company has recalled two lots of Seasonale birth control because the packages contain too ...

Teva Pharmaceutical Industries Ltd. engages ... hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN ...

The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to take down about two dozen patents for its asthma and COPD inhalers ...

Aug 21 (Reuters) - Teva Pharmaceutical (TEVA.TA), opens new tab will pay $225 million and divest its copycat version of a cholesterol drug as part of its settlement of price-fixing charges ...

By Jan Hoffman Teva Pharmaceuticals, one of the country’s biggest manufacturers of generic opioids, announced a settlement in principle with some 2,500 local governments, states and tribes over ...